Becker's Healthcare August 7, 2024
After securing FDA approval, Abbott Laboratories and Dexcom will soon launch the first over-the-counter continuous glucose monitors, The Washington Post reported Aug. 5.
The devices recently gained the regulatory greenlight, and both medical devicemakers are about to enter a market that includes more than 100 million people.
Margaret Kaczor Andrew, an analyst at William Blair, told the Post there are about 7.5 million diabetic patients in the U.S. who use insulin, meaning...
Today's Sponsors
Today's Sponsor